RxDoctor Payments Data

Bernadette Anderson, MD

Family Medicine · Columbus, OHNPI 1750366035

Payments from drug & device makers

$1,852in general payments, 2019–2025

Across 113 payments — averaging $16.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$779
  • Merck$239
  • Novo Nordisk$217
  • AbbVie$104
  • Xeris Pharmaceuticals, Inc.$83
  • Abbott$73
  • plus $357 from 10 others

What the payments were for

  • Food & beverage$1,846100%
  • Education$60%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,852 in reported general payments places this provider in the 70th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$37,914
Medicare patients
84
Services billed
862

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide29$44,168
MounjaroTirzepatide25$33,539
JanuviaSitagliptin Phosphate13$20,554
FarxigaDapagliflozin Propanediol13$8,985
ShingrixVaricella-Zoster Ge/As01b/Pf19$4,110
NorvascAmlodipine Besylate15$2,437
Atorvastatin Calcium187$2,033
Fluticasone-SalmeterolFluticasone Propion/Salmeterol18$1,604
Amlodipine Besylate287$1,512
SynthroidLevothyroxine Sodium42$1,445
Albuterol Sulfate HfaAlbuterol Sulfate49$1,430
Rosuvastatin Calcium90$1,421
CozaarLosartan Potassium16$1,268
Losartan Potassium99$949
Potassium Chloride54$909

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$217$44,16829 claims
Lilly USA, LLCMounjaro$50$33,53925 claims
MerckJanuvia$239$20,55413 claims
AstraZenecaFarxiga$779$8,98513 claims
GSKShingrix$36$4,11019 claims
AbbVieSynthroid$104$1,44542 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Columbus

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →